National Survey on Hypertension in General Practitioner (GP) Consultation - Full Text View

National Survey on Hypertension in General Practitioner (GP) Consultation (Prophyl GP)

This study has been completed.

First Received: June 10, 2008 Last Updated: August 4, 2009 History of Changes

Sponsor:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00695656

Purpose

To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in general practitioner consultation.

Condition
Hypertension

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Profile of Hypertensive Patients Seen in General Practitioner Consultation

Resource links provided by NLM:

MedlinePlus related topics: High Blood Pressure

U.S. FDA Resources

Further study details as provided by AstraZeneca:

Primary Outcome Measures:

Demographic, clinical and health care characteristics [ Time Frame: Once ]

Biospecimen Retention: None Retained

Biospecimen Description:

Enrollment:	2853
Study Start Date:	April 2008
Study Completion Date:	November 2008

Groups/Cohorts
1

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

First three consecutive patients with hypertension seen by general practitioner

Criteria

Inclusion Criteria:

male or female > or = 18 years old
Known hypertension
agree to take part in this study

Exclusion Criteria:

none

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00695656

Show 1387 Study Locations

Sponsors and Collaborators

AstraZeneca

Investigators

Study Director:

Castaigne, Medical Director

AstraZeneca

More Information

No publications provided

Responsible Party:	AstraZeneca Pharmaceuticals ( Alain Castaigne, Medical Director )
Study ID Numbers:	NIS-CFR-DUM-2007/7
Study First Received:	June 10, 2008
Last Updated:	August 4, 2009
ClinicalTrials.gov Identifier:	NCT00695656 History of Changes
Health Authority:	France: French Data Protection Authority

Keywords provided by AstraZeneca:

Hypertension
general practitioner consultation
Patients with hypertension

Additional relevant MeSH terms:

Vascular Diseases
Cardiovascular Diseases
Hypertension

ClinicalTrials.gov processed this record on February 08, 2010